Synonym |
BLN |
Species |
Aplysia californica |
Protein Accession |
Q9XSV2 |
Purity |
Greater than 95% |
Endotoxin Level |
Less than 1 EU/ug |
Biological Activity |
Stimulates smooth muscle contraction |
Expression System |
E. coli |
Fusion Tag |
None |
Predicted Molecular Mass |
2.5 kDa |
Formulation |
Lyophilized powder |
Reconstitution |
Reconstitute in water or buffer solution |
Storage & Stability |
Store at -20°C upon receipt, stable for up to 6 months at -20°C |
FAQ
What is Bradykinin-Like Neuropeptide (Aplysia californica)?
Bradykinin-Like Neuropeptide (Aplysia
californica) is a compound derived from the central nervous system of the sea slug Aplysia californica.
This neuropeptide has garnered significant attention in recent years due to its potential roles in
neurological research and possible therapeutic applications. The Aplysia californica, commonly known as
the California sea hare, is a marine mollusk traditionally studied for its large, accessible neurons.
Scientists are particularly interested in its nervous system because these large neurons offer a
straightforward way to navigate the complexities of cellular communication and behaviors in nervous
system functions. The Bradykinin-Like Neuropeptide in Aplysia has been found to exhibit properties
similar to those of bradykinin in humans, which is a peptide that causes blood vessels to dilate,
resulting in lowered blood pressure. In neurological research, bradykinin and its analogs are studied
for their roles in pain pathways, inflammation, and cellular communication. The study of Bradykinin-Like
Neuropeptide (Aplysia californica) is not only of interest for its physiological effects but also for
what its mechanisms can reveal about fundamental biological processes in not just invertebrates but
potentially vertebrates as well. Peptides like this one are often used as molecular tools to help
uncover the pathways and interactions that underlie various neurological and physiological responses.
Researchers hope that these insights can eventually lead to novel treatments or therapies for conditions
where these pathways are disrupted or dysfunctional. As with any compound of interest that affects the
nervous system, understanding the full range of effects, potential therapeutic windows, and any possible
side effects is critical. By continuing to study nature’s biochemical toolkit, researchers are
uncovering new perspectives on how neuropeptides can be harnessed for health benefits.
How does
Bradykinin-Like Neuropeptide (Aplysia californica) interact with the nervous
system?
Bradykinin-Like Neuropeptide (Aplysia californica) interacts with the nervous system by
modulating physiological processes that underlie neuromodulation. In the central nervous system of
Aplysia californica, these neuropeptides are part of the intricate network that regulates neuronal
activity and communication. The interaction with the nervous system begins at the neural receptors where
the peptide binds to specific sites, altering the electrical and chemical responses of neurons. The
consequence of this modulation is multifaceted. In many instances, Bradykinin-Like Neuropeptides can
influence the excitability of neurons, impacting how signals are initiated and propagated. These changes
can facilitate or inhibit the release of neurotransmitters, affecting synaptic transmission and
plasticity, which are essential for learning and memory. The role of neuropeptides in altering synaptic
strength and communication is a fundamental area of interest, as it can shed light on the mechanisms of
memory retention and learning, as well as the pathological progression of specific neurological
diseases. On a cellular level, the ligand-receptor binding that occurs can activate various
intracellular signaling cascades, leading to wide-ranging physiological outcomes. In inflammation, for
instance, bradykinin is known to enhance the permeability of blood vessels, promoting the influx of
immune cells to the site of injury or infection. In the context of Aplysia, the Bradykinin-Like
Neuropeptide is thought to be involved in stress response pathways, which has implications for
understanding how organisms respond to environmental and physiological stressors. Moreover,
neuropeptides can induce long-term changes in neuron structure and function, such as altering gene
expression and metabolic activity, further illustrating their potent and broad regulatory capabilities.
Because of these interactions, Bradykinin-Like Neuropeptide (Aplysia californica) is a critical subject
in neuropharmacology and biotechnology, offering a window into fundamental neuroscience research and
paving the way for new therapeutic strategies.
What potential applications might Bradykinin-Like
Neuropeptide (Aplysia californica) have?
Bradykinin-Like Neuropeptide (Aplysia californica) has
several potential applications that span across both research and therapeutic realms. One of the most
promising applications lies in its utility as a tool for neurological research. Because of the
neuropeptide’s role in synaptic modulation and cellular communication, it can be used to study the
fundamental processes that govern neuronal responses, synaptic strength, and neuroplasticity. This can
help in understanding the mechanisms behind learning, memory, and even neurodegenerative diseases.
Exploring such pathways can possibly lead to interventions that ameliorate or potentially reverse the
progression of diseases like Alzheimer's, Parkinson's, or other conditions characterized by impaired
neuron communication and plasticity. In addition to its research applications, the bradykinin-like
properties serve as a basis for investigating new pain management therapies. Bradykinin analogs are
often studied for their roles in pain and inflammation pathways, providing a model for designing new
analgesics or anti-inflammatory drugs that could offer alternatives to traditional pain management
strategies, which can be limited by efficacy issues or side effects like addiction. Furthermore, because
bradykinin is involved in the regulation of blood vessel permeability and inflammation, Bradykinin-Like
Neuropeptide (Aplysia californica) could have implications in cardiovascular research, particularly in
understanding and developing treatments for conditions involving blood pressure regulation and vascular
health. Another potential application is in stress physiology, where understanding how organisms respond
to and modulate stress at the molecular level can inform therapeutic approaches to stress-related
disorders. Finally, this neuropeptide might be employed in synthetic biology and bioengineering. Its
known effects could be used to design molecular systems or biosensors that respond to specific
biological stimuli, opening up avenues for biotechnological innovation. Each of these applications
reflects the broad and varied potential of Bradykinin-Like Neuropeptide (Aplysia californica),
showcasing its versatility as both a research tool and potential therapeutic agent in various
contexts.
What makes Bradykinin-Like Neuropeptide (Aplysia californica) unique compared to other
neuropeptides?
Bradykinin-Like Neuropeptide (Aplysia californica) holds a unique position among
neuropeptides due to several distinguishing factors that set it apart in the field of neural research
and its potential applications. Firstly, its origin from the central nervous system of Aplysia
californica provides researchers with a simplified and accessible model organism known for its
exceptionally large neurons, facilitating detailed cellular and molecular studies. This aspect is
particularly advantageous for unraveling the complexities of neural processes, offering insights that
can be extrapolated to more complex organisms, including humans. Another distinguishing feature is its
structural and functional similarity to bradykinin, a well-known peptide in mammalian systems that plays
a key role in inflammation, pain modulation, and vascular function. The cross-species examination of
this particular neuropeptide offers unique insights into the evolutionary conservation and divergence of
neuropeptide functions, allowing researchers to explore ancient biochemical pathways that inform current
biological functions and behaviors. Bradykinin-Like Neuropeptide (Aplysia californica) also serves as an
important model in studying stress response and adaptation at the neuronal level, offering unique
perspectives on how organisms balance external environmental pressures and internal physiological
states. As a result, this neuropeptide is invaluable for exploring the underlying genetics and molecular
biology of neurophysiological adaptations, providing clues to resilience mechanisms against stressful
stimuli, which can have implications for understanding stress-related disorders. Furthermore, its
ability to modulate neural pathways with high specificity highlights its potential as a scaffold for
designing selective receptor agonists or antagonists, which are fundamentally important in the
development of new pharmacological treatments targeting specific neural circuits. This specificity
promises fewer side effects and increased efficacy in designing therapeutic agents. Overall, the
combination of its unique origin, structural properties, and versatile functionalities differentiates
Bradykinin-Like Neuropeptide (Aplysia californica) from other neuropeptides, making it an essential
focus for both basic neuroscience research and applied scientific explorations.
How is
Bradykinin-Like Neuropeptide (Aplysia californica) studied in a laboratory setting?
Studying
Bradykinin-Like Neuropeptide (Aplysia californica) in a laboratory setting involves a variety of
sophisticated techniques aimed at unraveling its structure, function, and impact on the nervous system.
Researchers begin with isolating and extracting the neuropeptide from the nervous tissue of Aplysia
californica. This is typically achieved through methods such as chromatography which enables the
purification of specific peptide fractions. Once isolated, structural analysis is conducted using
technologies like mass spectrometry and nuclear magnetic resonance (NMR) spectroscopy, providing
detailed information about the peptide's amino acid composition and three-dimensional conformation.
Functional analysis is then carried out, often involving in vitro and in vivo experiments that assess
how the neuropeptide influences neuronal activity and behavior. In vitro techniques may include the use
of electrophysiological recordings to measure changes in membrane potential or ion currents in response
to the application of the neuropeptide. These electrophysiological studies can be conducted in isolated
neurons or on neuronal networks cultured in petri dishes, offering a controlled environment to dissect
the pathways and mechanisms modulated by the neuropeptide. Complementary to these approaches, genetic
and molecular biology tools are employed to understand how the interaction between Bradykinin-Like
Neuropeptide and its receptors triggers intracellular signaling cascades. This can involve gene
expression analyses using qPCR or RNA sequencing to identify downstream targets and pathways that are
differentially regulated following neuropeptide application. Additionally, the use of specific receptor
antagonists or gene knockout models can help in establishing causal relationships and elucidating the
precise molecular mechanisms at play. Animal models are pivotal in translating these findings to more
complex biological systems. Behavioral assays, for instance, are utilized to observe changes in
learning, memory, or stress response when the neuropeptide is administered. These studies are often
complemented by imaging techniques such as confocal microscopy or fMRI in larger animal models, helping
observers visualize changes in the nervous system in real-time. Collectively, these laboratory
approaches enable a comprehensive investigation into the multifaceted roles of Bradykinin-Like
Neuropeptide (Aplysia californica), paving the way for deeper insights into its potential applications
in neuroscience and medicine.
What are the challenges associated with the research of
Bradykinin-Like Neuropeptide (Aplysia californica)?
Researching Bradykinin-Like Neuropeptide
(Aplysia californica) presents a unique set of challenges that stem from both the biological and
technical complexity of working with neuropeptides. One primary challenge lies in the extraction and
purification processes. Given that this neuropeptide is derived from the nervous tissue of Aplysia
californica, obtaining sufficient quantities for study requires meticulous extraction techniques. Often,
advanced chromatography and purification methods must be employed to isolate the neuropeptide without
degradation or contamination, which can be labor-intensive and technically demanding. Another challenge
is the peptide's intrinsic properties and stability in various experimental conditions. Neuropeptides
are prone to rapid degradation in biological environments, which makes their study, particularly in
vivo, quite challenging. Ensuring stability requires well-planned experimental protocols and may involve
modifying the neuropeptide to resist enzymatic breakdown, which can potentially alter its natural
activity. Besides these biological hurdles, there are complexities related to modeling the peptide's
interaction in the nervous system. Understanding how Bradykinin-Like Neuropeptide interfaces with its
receptors and elicits cellular responses involves dissecting intricate signal transduction pathways.
This requires precise biochemical assays and the use of advanced molecular biology techniques,
presenting a steep learning curve and requiring significant expertise. Additionally, while Aplysia
californica serves as a highly valuable model organism due to its large neurons and relatively simple
nervous system, translating findings from this invertebrate model to more complex human systems involves
considerable uncertainty. Researchers face challenges in generalizing the outcomes, especially when it
comes to applications in human health, which may involve different receptor subtypes and signaling
pathways. Finally, funding and resources can also be limiting. Given the specificity of this research,
it requires specialized equipment and substantial investment in research teams and laboratory
infrastructure. Balancing these needs with available resources necessitates strategic planning and often
interdisciplinary collaboration. Despite these challenges, overcoming these obstacles can lead to
significant advancements in our understanding of neuropeptides and their potential therapeutic
applications, advocating for continued innovation and investment in this area of study.